SNCA and Parkinson disease: Expression of the PD-linked mutant CHCHD2 T61I with α-synuclein also synergistically exacerbates survival and motor deficits (Ikeda et al., 2019), demonstrating pathological synergy between α-synuclein and the CHCHD2 T61I mutation.